Media

For more information and details relevant for media, see our News and events section.

For enquiries from media, please contact the EMA press office.

Featured information for journalists

EMA communication activities

We asked stakeholders for feedback on our communication activities in a survey in 2022 and captured the results in a newly-published report. The findings help us set targets, address areas for improvement and measure progress. We thank all respondents for their feedback.

EU agencies promoting a One Health approach

EMA and other scientific EU agencies responsible for human, animal health and environmental protection have established a task force to coordinate activities and share information, promoting a joined-up One Health approach. A paper is available containing more details.

2022 annual report

Navigate through the digital report to view interviews, short videos and an interactive timeline of the Agency’s main activities in 2022. Read the traditional PDF version to see additional figures and statistics on EMA's regulatory procedures and activities.

Human medicines: highlights of 2022

In 2022, EMA recommended 89 medicines for marketing authorisation. Of these, 41 had a new active substance which had never been authorised in the European Union before. These included two vaccines and two treatments for COVID-19.

Veterinary medicines: highlights of 2022

In 2022, EMA recommended 10 medicines for marketing authorisation. Of these, three had a new active substance. Two are vaccines, including one new biotechnological vaccine.

European medicines agencies network strategy to 2025

The strategy sets out how the network will continue to enable the supply of safe and effective medicines, in the face of developments in science, medicine, digital technologies, globalisation and emerging health threats, such as the COVID-19 pandemic.

Search and filter our news announcements.

You can find out more on how we work including statistics and information on financial management.